NCT00423306View on ClinicalTrials.gov

A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma

PHASE2UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
HEPATOCELLULAR CARCINOMA
Interventions
DRUG

Darinaparsin

420 mg/m2 of Darinaparsin given twice weekly for three weeks, followed by one week of rest, for up to 6 months

Trial Locations (6)

Unknown

Miami

Atlanta

Boston

Kansas City

New York

Seattle

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY